<DOC>
	<DOCNO>NCT02174653</DOCNO>
	<brief_summary>The aim study evaluate safety intake EPs速 7630 long-term ( 4 month ) medication . The protective effect EPs速7630 effect cold episode also study .</brief_summary>
	<brief_title>Safety Intake Effect EPs速 7630 ( Extract Roots Pelargonium Sidoides )</brief_title>
	<detailed_description>The main objective clinical trial evaluate safety EPs速 7630 intake - use continuous protection onset cold symptom - adult participant long-term ( 4 month ) medication . Due sparseness empirical data population setting , confirmatory hypothesis formulate data analyse descriptively .</detailed_description>
	<mesh_term>Common Cold</mesh_term>
	<criteria>1 . Adult male female participant ( least 18 year old ) 2 . Participant provide write informed consent accordance legal requirement 3 . Participant willingness ability comply procedures clinical trial available duration study 4 . Participant good physical mental condition 5 . Participant experience least 2 cold per year last 12 month 1 . Chronic respiratory tract lung disease ( e.g . chronic bronchitis , COPD , bronchial asthma , cystic fibrosis , active pulmonary tuberculosis , lung cancer ) 2 . History heart , renal , liver , neuromuscular disease and/or immunosuppression 3 . Known allergic bronchial asthma 4 . Known suspected congenital anomaly heart , kidney , liver , mental disability 5 . Participant concomitant medication might impair interpretation trial result ( e.g . herbal medication common cold investigational product , pain relief medication Paracetamol Ibuprofen ) 6 . Women childbearing potential adequate effective contraception ( MHRA , 2010 ) : Established use oral , injected implant hormonal method contraception Placement intrauterine device ( IUD ) intrauterine system ( IUS ) Barrier method contraception : Condom and/or Occlusive cap ( diaphragm cervical/vault cap ) spermicidal foam/gel/film/cream/suppository Sexual abstinence Vasectomised partner 7 . Female participant pregnant , lactate plan pregnancy course clinical trial 8 . Participant cold symptom inclusion 9 . Current intake antimicrobial and/or antiviral medication reason 10 . Participant know suspected history alcohol drug abuse 11 . Heavy smoking ( 10 cigarette per day ) 12 . Psychiatric disorder may influence result trial , epilepsy , suicide attempt 13 . Planned surgical intervention trial 14 . Known gastrointestinal disorder uncertain absorption orally administer medication ( e.g . partial total gastrectomy , enterectomy , inflammatory bowel disease , celiac disease , symptomatic lactose intolerance , dysbacteriosis ) associate diarrhoea 15 . Known suspected hypersensitivity active substance excipients investigational product 16 . Known clinically relevant laboratory abnormality 17 . Participant increase tendency bleed , especially nasal gingival bleed 18 . Previous ( within last 3 month prior visit 1 ) concomitant treatment coagulationinhibiting drug warfarin 19 . Participation clinical trial time within last 4 week prior inclusion present study 20 . Previous randomisation present clinical study 21 . Irresponsible subject unable understand nature , mean consequence trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>